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AMPK/HuR-Driven IL-20 Post-Transcriptional
Regulation in Psoriatic Skin
Geneviève Garcin1, Isabelle Guiraud2, Matthieu Lacroix3, Clémence Genthon4, Stéphanie Rialle4,
Jean-Marie Joujoux5, Laurent Meunier6, Thierry Lavabre-Bertrand2, Pierre-Emmanuel Stoebner6,7 and
Lionel Le Gallic2,7
IL-20 is involved in the development of skin psoriasis. The molecular mechanisms underlying IL-20
overexpression in psoriatic epidermis remain to be elucidated. We showed that IL-20 was primarily upregulated
in psoriatic skin at the post-transcriptional level. The RNA-binding protein HuR relocalized to the cytoplasm of
keratinocytes (KCs) of psoriatic patients, suggesting that it stabilizes numerous transcripts, as observed in the
human KC cell lines used to assess IL-20 mRNA. We characterized epidermal HuR RNA targets in psoriatic skin
using ribonucleoprotein immunoprecipitation analyzed via high-throughput sequencing. Numerous transcripts
that are upregulated in psoriasis were targeted by HuR, supporting the participation of HuR in pathogenic
processes such as morphological changes, innate and adaptive immune responses, and metabolic inﬂammatory
responses. Finally, we identiﬁed the metabolic sensor AMP-activated protein kinase (AMPK) as being responsible
for HuR cytoplasmic relocalization because its activity was severely impaired in human psoriatic epidermis, and
in vivo drug-mediated AMPK inhibition in mouse epidermis promoted HuR cytoplasmic localization, IL-20
overproduction, acanthosis, and hyperkeratosis. These results provide insights into the molecular links between
metabolism and post-transcriptional networks during chronic inﬂammation.
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INTRODUCTION
The IL-20 subfamily of cytokines (IL-19, IL-20, IL-22, IL-24,
and IL-26) (Rutz et al., 2014) has an important role in the
pathogenesis of psoriasis because of their pro-inﬂammatory
proprieties and overexpression in this disease (Rutz et al.,
2014). Indeed, IL-19 and IL-24 and, more markedly, IL-20 and
IL-22 have been shown to mimic certain classical psoriatic
features in reconstituted human epidermis models (Sa et al.,
2007), and mouse models overexpressing IL-20, IL-22, or IL-24
exhibit a psoriasis-like appearance (Blumberg et al., 2001; He
and Liang 2010). The primary source of IL-22 and IL-26 is
restricted to the lymphoid lineage, certain speciﬁc activated
T-cell subpopulations (T helper type 22, T helper type 1, and
T helper type 17), and natural killer cell subsets, whereas both
immune cells and tissue cells secrete IL-19, IL-20, and IL-24
(Sabat, 2010). IL-20 has an important role in the later effector
phase of psoriasis pathogenesis, during which it inhibits the
terminal differentiation of keratinocytes (KCs) and contributes
to antimicrobial competence and epidermal inﬁltration by
neutrophilic granulocytes (Sabat and Wolk, 2011). Patients
with psoriasis exhibit an increased level of IL-20 in lesional
skin (LS) and in the blood, where it correlates with the Psoriasis
Area Severity Index score (Sabat and Wolk, 2011). IL-20
binds to receptor heterodimers that are found on KCs but not
on immune cells. Despite their central role in psoriasis,
the molecular mechanisms that lead to the overexpression
of the IL-20 subfamily of cytokines have been rarely
investigated.
In the present study, we show that IL-20 is primarily
upregulated in psoriatic skin at the post-transcriptional level
via mRNA stabilization. We found that the RNA-binding
protein HuR (Srikantan and Gorospe, 2012) binds to and
regulates IL-20 mRNA and relocalizes to the cytosol of
psoriatic KCs. We further identify additional HuR targets in
psoriatic skin using ribonucleoprotein immunoprecipitation
analyzed by high-throughput sequencing (RIP-Seq).
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Max Mousseron (IBMM), CNRS UMR 5247, Faculté de Médecine Montpellier-
Nîmes, Université de Montpellier, Nîmes, France; 3Institut de Recherche en
Cancérologie de Montpellier (IRCM), Institut régional du Cancer Montpellier
(ICM), INSERM U896, Université de Montpellier, Montpellier, France;
4Montpellier Genomix (MGX), Institut de Génomique Fonctionnelle (IGF),
CNRS INSERM UMS3426, Université de Montpellier, Montpellier, France;
5Service d’Anatomopathologie, Centre Hospitalier Universitaire de Nîmes,
Nîmes, France and 6Service de Dermatologie, Centre Hospitalier Universitaire
de Nîmes, Nîmes, France
Correspondence: Pierre-Emmanuel Stoebner, Service de Dermatologie, Centre
Hospitalier Universitaire de Nîmes, Nîmes 30029, France or Lionel Le Gallic,
School of Medicine, University of Montpellier, NIMES Cedex 2 30908, France.
E-mail: pierre.stoebner@chu-nimes.fr or lionel.le-gallic@univ-montp1.fr
7The last two authors contributed equally to this work.
Received 26 January 2015; revised 18 May 2015; accepted 23 June 2015;
accepted article preview online 15 July 2015; published online 6 August 2015
Abbreviations: 3′UTR, 3′ untranslated region; ActD, actinomycin D;
AMPK, AMP-activated protein kinase; CompC, compound C; IHC,
immunohistochemistry; IP, immunoprecipitation; KC, keratinocyte;
LS, lesional skin; NLS, non-lesional skin; RIP-Seq, ribonucleoprotein
immunoprecipitation analyzed by high-throughput sequencing
2732 Journal of Investigative Dermatology (2015), Volume 135 © 2015 The Society for Investigative Dermatology
Consistent with comorbidity (Armstrong et al., 2013) and
enzymatic (Halprin and Ohkawara, 1966) studies, we
demonstrate metabolic alterations in psoriasis based on the
apparent decrease in the activity of the metabolic sensor
AMP-activated protein kinase (AMPK) (O'Neill and Hardie,
2013) in psoriatic KCs. Finally, a speciﬁc AMPK inhibitor
causes HuR cytosolic localization and IL-20 mRNA stabiliza-
tion in human KCs. Topical application of the AMPK inhibitor
on mouse skin causes HuR cytosolic localization and IL-20
overproduction and initiates certain histological features of
psoriasis. These ﬁndings suggest that metabolic disorders
affecting AMPK activation in KCs are important in the
pathophysiology of psoriasis, permitting HuR-mediated stabi-
lization of numerous mRNAs, including IL-20 mRNA.
RESULTS
IL-20 mRNA is stabilized by cellular stresses
To study IL-20 induction in a cellular model, we treated the
HaCaT KC cell line with different cellular stresses, such as
anisomycin (protein synthesis inhibition and p38 MAP kinase
activation) or UVB radiation (cell damage stress) with or
without actinomycin D (transcriptional inhibition). IL-20
mRNA levels and IL-20 gene transcription were evaluated
using quantitiative PCR primers that discriminate IL-20 mRNA
and IL-20 precursor mRNA (pre-mRNA). IL-20 exhibited
strong mRNA induction in response to anisomycin and UVB
exposure (Figures 1a and b, respectively). Under identical
conditions, IL-20 pre-mRNA did not increase, except in
response to 20mJ cm− 2 UVB and 8 hours after anisomycin
treatment (Figures 1d and c, respectively), at which dose and
time the increase was limited and not signiﬁcant. This modest
variation in the transcriptional rate could suggest that IL-20
mRNA stability is a limiting step for IL-20 mRNA accumula-
tion. The kinetics of mRNA stability following the inhibition of
transcription with actinomycin D indicated that IL-19, IL-24,
and, to a greater degree, IL-20 were unstable in non-stressed
cells but were efﬁciently stabilized following UVB irradiation
(Figure 1e). Collectively, these results indicated that (i) IL-20
mRNA was extremely unstable in non-stressed cells, and (ii)
its induction in response to cellular stresses was predomi-
nantly mediated by its stabilization. Conversely, IL-19 and
IL-24 mRNA induction was associated with both transcrip-
tional and mRNA stabilization mechanisms. Consistent with
these results, post-transcriptional regulatory elements present
within the 3′ untranslated region (3′UTR) of the IL-20 cytokine
subfamily were more numerous and relevant in IL-20 (and
IL-22) than in IL-19 and IL-24 (and IL-26; Figure 1f).
IL-20 mRNA is stabilized in psoriatic skin
We used immunohistochemistry (IHC) to conﬁrm that KCs are
the primary source of IL-20 in psoriatic lesions (Figure 2a).
DEFB4A, a marker of the severity of psoriasis (Jansen et al.,
2009), was increased (⩾2-fold) at the mRNA level in LS
compared with non-lesional skin (NLS) in the entire patient
cohort (n=17; Figure 2b). IL-20 mRNA was overexpressed in
LS in all tested patients, and IL-22 and IL-24 mRNA were
increased in 16 of 17 patients, IL-26 in 15 of 17 patients, and
IL-19 in 12 of 17 patients (Figure 2c). These results are
consistent with previous studies (Sabat and Wolk, 2011). The
IL-20 pre-mRNA level was not signiﬁcantly increased in LS
versus NLS and does not account for the upregulation of IL-20
mRNA in psoriasis. This result suggested that the upregulation
in LS occurred at the mRNA level via a post-transcriptional
mechanism(s) (Figure 2d). Similar results were obtained with
IL-22 pre-mRNAs. Because of patient variations, IL-24 pre-
mRNA was not signiﬁcantly upregulated. In contrast, the levels
of IL-19 and IL-26 pre-mRNAs were signiﬁcantly increased in
LS compared with NLS, suggesting that the increased gene
transcription was a major contributor to the induction of mRNA
in LS. We next established the lack of a correlation between the
mRNA and the pre-mRNA levels in NLS for each of the ﬁve
cytokines (Figure 2e). In contrast, the mRNA levels in LS
appeared to signiﬁcantly correlate with the pre-mRNA levels
for IL-20, IL-19, IL-22, and IL-24. Indeed, the mechanisms
uncoupling the mRNA levels from the pre-mRNA levels in NLS
were not present in LS. Because IL-20 mRNA was regulated by
the mRNA decay machinery and no increase in IL-20 pre-
mRNA (i.e., transcriptional upregulation) was found in LS, IL-20
mRNA may be (i) destabilized in NLS and (ii) stabilized in LS.
Comparatively, IL-22 mRNA was also regulated via an increase
in stability in LS, whereas IL-19, IL-24, and IL-26 mRNAs were
(i) destabilized in NLS and (ii) regulated via an increase in
mRNA transcription and stability in LS.
HuR regulates IL-20 mRNA stability and relocalizes to the
cytoplasm of psoriatic KCs
Figure 2 indicates that the pathways involved in the
stabilization of messengers were activated in psoriasis; there-
fore, we focused on this aspect. p38 MAP kinases, one of
the best-characterized mRNA stabilization pathways through
5′-AUUUA-3′ motifs in the mRNA 3′UTR (Winzen et al.,
1999), have been described to be involved in chronic
inﬂammatory diseases, including psoriasis (Johansen et al.,
2006). IL-20 contains numerous AUUUA motifs in its 3′UTR,
and the inhibition of p38 MAP kinases nearly abrogated the
IL-20 response to cellular stress (Supplementary Figures S1A
and S1B online). However, it was shown that epidermal p38α,
but not myeloid p38α, is not essential in skin inﬂammation in
mice (Kim et al., 2008). Our results supported the relative
importance of p38 MAP kinases and/or the target MK2 in the
inﬂammatory response of KCs, as p38 and MK2 activation,
estimated by IHC, was limited to (prometa-)metaphasic KCs
(Supplementary Figures S1C–S1F online) and is thus the
consequence of a high mitotic rate in the psoriatic epidermis.
Another mechanism that may account for the mRNA
stabilization is mediated by the RNA-binding protein HuR
(Kim and Gorospe, 2008). Indeed, the IL-20 3′UTR contains the
highest afﬁnity HuR heptamer-binding sites (5′-UUUUUUU-3′;
Lebedeva et al., 2011), and we demonstrated that HuR could
bind to IL-20 mRNA (Figure 3a). As shown in Figure 3b, the
increase in IL-20 mRNA induced by anisomycin was severely
impaired by small interfering RNA-mediated HuR knock-
down, stressing the importance of HuR in IL-20 mRNA
overexpression. HuR mRNA and protein levels were found to
be similar in LS compared with NLS (Figures 3c and d).
However, IHC analysis indicated that the intracellular
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distribution of HuR in KCs was predominantly nuclear in NLS
and predominantly cytoplasmic in LS epidermis (Figure 3e).
Because HuR stabilizes mature mRNAs in the cytoplasm
(Srikantan and Gorospe, 2012), these results suggested that
HuR could stabilize IL-20 mRNA and numerous other mRNAs
by interacting with compatible 3′UTRs in LS epidermis.
HuR binds numerous transcripts involved in the pathogenesis of
psoriasis
To identify RNA targets of HuR in psoriatic skin, we performed
RIP-Seq experiments (Srikantan and Gorospe, 2011)
(Supplementary Data S1 online). Pre-mature (i.e., non-spliced)
RNAs and mature (i.e., spliced) RNAs targeted by HuR and
identiﬁed in our RIP-Seq in NLS and LS represented 34.2 and
17.4% of the entire transcriptome, respectively, which is
consistent with previous studies investigating HuR targets
using photoactivatable-ribonucleoside-enhanced crosslinking
and immunoprecipitation (Lebedeva et al., 2011; Mukherjee
et al., 2011). Moreover, 42.9% of the pre-mature RNA and
45.8% of the mature RNA targets identiﬁed in LS have been
described as HuR targets by at least one photoactivatable-
ribonucleoside-enhanced crosslinking and immunoprecipita-
tion study (Figure 4a). Mature RNAs with increased HuR
binding in psoriatic skin (log2⩾0.5) belong to the epithelial
lineage, whereas mature RNAs with the lowest fold binding
(log2⩽−0.5) belong to other lineages (Figure 4b). HuR
activity was displaced from the nucleus to the cytoplasm in
LS based on a 55.5% decrease in total pre-mature RNA reads
and a 48.4% increase in total mature RNA reads compared
with NLS (Figure 4c).
The intersection between our RIP-Seq and expression
array studies (Suárez-Fariñas et al., 2010) indicated an over-
representation of upregulated (47.6%) compared with
downregulated (18.4%) transcripts (Figure 5a). This over-
representation was more pronounced when we considered
only transcripts with an increased fold binding for HuR in LS
(log2⩾0.5): 47.6% compared with the transcripts that were
downregulated (2.6%; Figure 5b).
To investigate the relevance of our HuR RIP-Seq, we used
quantitative PCR to evaluate certain genes expressed in KCs
(Figure 5c). All three evaluated transcripts that were upregu-
lated in psoriasis and present in the RIP-Seq (CXCL-10,
DEFB4A, and SLC6A14) were downregulated by at least 50%
in HaCaT KCs (unstimulated or anisomycin-stimulated)
following small interfering RNA-mediated HuR knockdown
and appeared to be relevant HuR targets. The upregulated
transcripts that failed to bind HuR in the RIP-Seq exhibited
only a mild reduction (o25% downregulation); however,
CYP7B1, which was excluded from the RIP-Seq for minor
criteria (9 instead of 10 RIP-Seq reads, see Supplementary
Materials and Methods online), exhibited greater than 50%
inhibition. In contrast, two evaluated genes (CCL27 and
FA2H) known to be downregulated in psoriasis and not
present in HuR RIP-Seq were not affected by HuR knock-
down. Interestingly, 12 of 34 transcripts of genes that have
been implicated in psoriasis by genome-wide association
studies (Yu et al., 2008) appeared to be targeted by HuR
(Figure 5d). Numerous targets important for psoriatic patho-
physiology bound to HuR in LS more abundantly than in
NLS (e.g., CXCL-10, IL17RA, IVL, HERC6, HLA-DPA1, HLA-E,
IL36G, KRT17, LIPG, NAT9, PIM1, PSMA6, PSORS1C2,
RPS6KB2, REL, RHEB, SERPINB13, or SPINK5); however, the
RIP-Seq analysis was unable to detect IL-20 subfamily cytokine
mRNA or the mRNA of other cytokines, such as IL-8, which is
targeted by HuR (Nabors et al., 2001). This lack of detection
was likely associated with the difﬁculty encountered in
immunoprecipitating low-level transcripts from skin samples
and indicated that our analysis may have underestimated the
number of HuR-targeted transcripts. Next, we explored path-
ways that were modulated by HuR in LS by cross-matching
HuR mature RNA targets (exhibiting a log2 increase ⩾0.5-fold)
using the Kyoto Encyclopedia of Genes and Genomes pathway
database (Figure 5e), and we identiﬁed several pathways that
have been implicated in the pathogenesis of psoriasis (see
Discussion section).
AMPK inactivation leads to HuR cytoplasmic localization and
IL-20 mRNA stabilization and initiates epidermal changes in
mouse skin
Using IHC, we explored whether known HuR shuttling
regulators (Kim and Gorospe, 2008) were affected in psoriatic
skin. Phosphorylated Cdk1 and protein kinase Cα labeling were
similar in LS and NLS (data not shown). Phosphorylated
AMPK labeling was predominantly detected in the basal layer
of NLS epidermis (Figure 6a). Conversely, phosphorylated
AMPK labeling was essentially absent in LS. To investigate the
potential role of a decrease in AMPK activity, we examined the
inﬂuence of compound C (CompC), a speciﬁc AMPK inhibitor
(Zhou et al., 2001), on HuR subcellular localization and IL-20
mRNA stabilization. As shown in Figure 6b, HuR was primarily
nuclear in untreated HaCaT cells, whereas exposure to CompC
triggered an increase in cytoplasmic HuR. IL-20 mRNA decay
following actinomycin D addition was primarily counteracted
by CompC, as 30% of the mRNA remained after 120 minutes
(Figure 6c). These observations suggested that AMPK inactiva-
tion in psoriasis may be responsible for the relocalization of
Figure 1. IL-20 production is regulated at the post-transcriptional level in HaCaT cells. (a) IL-19, IL-20, and IL-24 mRNA expression in response to anisomycin
(400 ngml−1). (b) UVB dose–dependent mRNA expression of IL-19, IL-20, and IL-24 (± SEM; n=3; c, control). (c) IL-19, IL-20, and IL-24 pre-spliced mRNA
expression in response to anisomycin (400 ngml−1). (d) IL-19, IL-20, and IL-24 pre-spliced mRNA expression in response to increasing UVB doses. a–d± SEM;
n= 3; *Po0.05, **Po0.005, ***Po0.001, and ****Po0.0001. (e) Actinomycin D (ActD; 5 μgml−1)-mediated termination of transcription in growing (open
squares) versus UVB (ﬁlled squares)-irradiated (30 mJ cm−2 4 hours prior to ActD) cells for IL-19, IL-20, and IL-24 mRNAs (one representative is shown; n=3).
(f) Post-transcriptional regulatory elements in IL-20 family 3′UTRs, such as AU-rich elements (5′-AUUUA-3′, 5′-UAUUUAU-3′, and 5′-WWWWAUUUAW
WWW-3′), HuR motifs (5′-UUUUUUU-3′, 5′-UUUAUUU-3′, and 5′-UUUGUUU-3′), and microRNAs with conserved matches.
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HuR to the cytoplasm of KCs to promote the stabilization of
IL-20 and other mRNAs. To address this question, we used a
mouse skin model. Normal mouse epidermis shares molecular
features of human epidermis: cytoplasmic phosphorylated
AMPK labeling, predominant nuclear HuR localization, and
minimal IL-20 levels (Figure 6d). The daily application of
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CompC on shaved mouse skin (n=6; Figure 6d) induced
histologically focal epidermal acanthosis and hyperkeratosis
that were less widespread and pronounced than those observed
following SDS application (Kim et al., 2008). Moreover,
CompC application led to a decrease in phosphorylated
AMPK labeling, HuR cytoplasmic relocalization, and an
increase in IL-20 labeling in mouse epidermis. SDS-treated
mice also exhibited epidermal relocalization of HuR and an
increase in IL-20 labeling but to a lesser extent. Collectively,
these results suggest that AMPK inactivation in KCs promotes
the cytoplasmic relocalization of HuR, stabilization of IL-20
mRNA, and overproduction of IL-20, which in turn induces
epidermal changes.
DISCUSSION
Changes in mRNA abundance have a dominant role in
determining the protein levels (Jovanovic et al., 2015),
whereas RNA processing degradation affects few genes,
albeit with important functions (Rabani et al., 2014). Indeed,
the role of transcriptional regulation in psoriasis has been well
documented, e.g., the inhibition of NF-κB in IL-24 induction
(Kumari et al., 2013), and it is supported in the present study
by the behavior of IL-19, IL-24, and IL-26. Here, we focused
on the post-transcriptome because it is implicated in the
expression of all IL-20 family members and because over-
expression of IL-20 appears to be primarily a consequence of
post-transcriptional regulation. We provide compelling evi-
dence implicating HuR in the stabilization of mRNAs in
psoriatic skin. IL-20 mRNA is targeted and regulated by HuR
in human KCs, and IHC and RIP-Seq analyses support the
translocation of HuR from the nucleus to the cytoplasm in
lesional epidermis. Nuclear HuR can interact with pre-mature
RNAs and affect their processing (Lebedeva et al., 2011;
Mukherjee et al., 2011), and cytoplasmic HuR translocation is
critical for HuR-mediated stabilization of mRNAs (Wang
et al., 2002). HuR mRNA targets are considered to comprise a
large portion of the transcriptome (approximately 15%) and to
be important for cell growth, proliferation, death, and immune
responses (Srikantan and Gorospe, 2012). HuR translocation
has been suspected in chronic inﬂammatory diseases, such as
asthma (Fan et al., 2011), and has been reported in certain
cancers (Srikantan and Gorospe, 2012). However, to the best
a
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Figure 2. IL-20 overexpression in psoriasis is a consequence of mRNA stabilization. (a) Immunohistochemical (IHC) staining of IL-20 in non-lesional skin (NLS)
and lesional skin (LS; one patient, representative of ﬁve). Scale bars = 200 μm for original magniﬁcation of 20× and 50 μm for original magniﬁcation of 100× .
(b) DEFB4A mRNA expression in punch biopsies (± SEM; n=17; ****Po0.0001) for NLS (open circles) and LS (ﬁlled circles). (c) Identical results for IL-19, IL-20,
IL-22, IL-24, and IL-26 mRNA expression (***Po0.001, ****Po0.0001). (d) IL-19, IL-20, IL-22, IL-24, and IL-26 pre-mRNA expression (***Po0.001 for NLS
(open circles) or LS (ﬁlled circles)). (e) Spearman’s rank correlation analysis and log10 plots between pre-mRNA (abscissa) and mRNA expression (ordinate) levels
of IL-19, IL-20, IL-22, IL-24, and IL-26 in NLS and LS (*Po0.05, **Po0.005, and ****Po0.0001).
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of our knowledge, HuR targets have not been determined in
any human disease, including psoriasis.
We found that pathways that could be affected by HuR
cytoplasmic localization in psoriasis include adherens junction
and focal adhesion pathways that participate in morphological
and transduction changes in psoriatic KCs. Interestingly, innate
and adaptive immune responses, which are an important
feature in psoriasis pathophysiology, are also targeted by HuR.
Indeed, KCs are an important component of the immune
system, expressing FcgRIII, which is present in RIP-Seq, and
molecules that are implicated in internalization (Gutowska-
Owsiak and Ogg, 2012). Finally, the phosphatidylinositol
3-kinase/AKT/mammalian target of the rapamycin (PI3K/AKT/
mTOR) pathway is also targeted by HuR cytoplasmic
relocalization, as indicated by the Kyoto Encyclopedia of
Genes and Genomes occurrences of inositol phosphate
metabolism, mTOR, phosphatidylinositol, and insulin
signaling pathways. Positive feedback of HuR in the AKT
pathway, which is involved in the pathogenesis of psoriasis,
(Mitra et al., 2012; Roller et al., 2012; Buerger et al., 2013), has
been reported (Singh et al., 2013).
Finally, AMPK activity, which is a sensor of cellular energy
and an antagonist of the PI3K/AKT/mTOR pathway (Inoki et al.,
2012), appears to decrease in psoriatic lesional epidermis.
Moreover, CompC, an AMPK inhibitor, induces HuR
cytoplasmic localization, stabilizes IL-20 mRNA in human
KCs, and initiates certain epidermal psoriatic histological
features. Alterations in carbohydrate metabolism have been
described in psoriasis for decades and are consistent with
our results. AMPK activation leads to the stimulation of energy-
producing pathways such as glycolysis. When AMPK is
inactivated, ATP-consuming pathways such as glycogenesis
are promoted. Indeed, a high level of glucose utilization
without an increase in glycolysis, leading to the use of glucose-
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Figure 3. HuR regulates IL-20 mRNA and relocalizes in the cytoplasm of keratinocytes in psoriasis. (a) DNA melting curve analysis from IL-20 quantitative PCR
following mock or HuR immunoprecipitations (IPs). HaCaT cells were previously irradiated (red line) or not (black line) for 4 hours with UVB (30mJ cm−2).
(b) HaCaT cells were transfected with a control small interfering RNA (siRNA) or independently with two HuR-speciﬁc siRNAs and stimulated with anisomycin
(400 ngml−1 for 7 hours, short dark line) or not stimulated. Left: HuR protein expression. Right: IL-20 mRNA level, average of both HuR-speciﬁc siRNAs (± SEM;
n= 3 for each siRNA; ***Po0.0005 and ****Po0.0001). (c) HuR mRNA expression in non-lesional skin (NLS; open circles) and lesional skin (LS; ﬁlled circles;
± SEM; n= 14). (d) Western blot analysis of samples from patients P1–P4. Left: NLS. Right: LS. (e) Immunohistochemistry for HuR in NLS and LS (one patient,
representative of ﬁve). Scale bars=200 μm for original magniﬁcation of 20× and 50 μm for original magniﬁcation of 100× .
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6 phosphate via the pentose phosphate pathway (Herdenstam
1962; Halprin and Ohkawara, 1966) and to glycogen
accumulation (Harmon and Phizackerley, 1984), has been
described in the psoriatic epidermis. Moreover, numerous
common drugs used to treat psoriasis are considered to
enhance AMPK activity, such as vitamin D (Hadad et al.,
2008) or retinoic acid (Lee et al., 2008). Furthermore,
methotrexate induces the accumulation of aminoimidazole
carboximide ribonucleotide (Beckers et al., 2006), which is a
potent AMPK activator. Collectively, these ﬁndings related to
metabolism, molecular interactions, and drug therapy reinforce
the importance of AMPK inhibition in psoriasis. Notably, UVB
is known to decrease AMPK activity and relocalize HuR to the
cytosol (Zhang and Bowden, 2008), and we demonstrated that
UVB promotes IL-20 induction in KCs, apparently in contra-
diction with the efﬁcacy of UVB treatment for psoriasis.
However, UVB therapy involves many other mechanisms and
cell lineages as for example the UVB-induced immune
suppression mediated by Treg cells following amphiregulin
stimulation by basophils (Meulenbroeks et al., 2015).
In summary, we provide compelling evidence for the
existence of a pathogenic cascade linking AMPK inactivation,
HuR cytoplasmic relocalization, and increased IL-20 stabili-
zation in the psoriatic epidermis. Our ﬁndings further support
the important post-transcriptional regulatory role of HuR in
the pathogenesis of psoriasis and implicate HuR in the
psoriatic KC response to metabolic stress. Understanding the
contribution of this potential pathway to psoriasis will be
enhanced by future studies that will include both therapeutic
targeting of AMPK and HuR and relevant genetically modiﬁed
animal models.
MATERIALS AND METHODS
Human tissue samples
We used tumor bank facilities offered by the University Hospital
Carémeau, Nîmes (France). This was an open study that was approved
by the ethics committee of the University Hospital of Carémeau, Nîmes
(France), in accordance with French laws and regulations, and thus all
patients provided written consent prior to study participation. The
included patients with chronic plaque-type psoriasis had not received
topical anti-psoriatic therapy during the previous 2 weeks or systemic
therapy during the previous 4 weeks. Keratome biopsies, which were
used for IHC, quantitative real-time reverse transcriptase–PCR, and RIP-
Seq, were harvested from LS and NLS (at a distance of at least 5 cm from
a lesional plaque) in patients with plaque-type psoriasis.
Histology
For human samples, formalin-ﬁxed parafﬁn-embedded tissue sec-
tions (7 μm) were used for immunoperoxidase staining. The sections
were counterstained with Harris hematoxylin (Sigma-Aldrich, St.
Louis, MO). Serial sections (4 μm) of formalin-ﬁxed parafﬁn-
embedded mouse back skin were stained with hematoxylin-eosin-
safran or used for immunoperoxidase staining and counterstained
with Harris hematoxylin. For human and mouse immunoperoxidase
staining, negative controls were processed with a matched control
antibody. All sections were observed with an Olympus AX70
microscope (Olympus, Tokyo, Japan).
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Figure 4. HuR binding to mature RNAs is increased in psoriasis. (a) Venn diagrams comparing our biopsies for HuR RIP-Seq with published HuR PAR-CLIPs for
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binding in involved versus uninvolved skin. (c) Total pre-mature RNA and mature RNA reads in the RIP-Seq for NLS and LS. LS, lesional skin; NLS, non-lesional
skin; PAR-CLIP, photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation; RIP-Seq, ribonucleoprotein immunoprecipitation analyzed by
high-throughput sequencing.
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Figure 5. HuR binds numerous transcripts involved in psoriasis pathophysiology. (a) Comparison of ribonucleoprotein immunoprecipitation analyzed by high-
throughput sequencing (RIP-Seq) HuR mRNA targets (Supplementary Data S1 online, exonic sheet) with up- and downregulated genes found in published
psoriasis transcriptomes (Suárez-Fariñas et al., 2010). (b) The same analysis with RIP-Seq HuR mRNA targets exhibiting an increased fold binding (log2⩾0.5) to
HuR in lesional skin (LS) versus non-lesional skin (NLS). (c) Small interfering RNA (siRNA) knockdown of HuR. HaCaT cells were transfected and stimulated as
described in Figure 3b (± SEM; n= 3 for each siRNA; *Po0.05, **Po0.005, and ***Po0.0005), and the expression of certain transcripts was determined by
qPCR. (d) Table of genes suggested to be implicated in psoriasis by genome-wide association studies (Yu et al., 2008) that appeared to be HuR targets in our
RIP-Seq analysis (log2-fold binding in LS). (e) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of HuR mature RNA targets exhibiting a log2⩾0.5-fold
increased binding in LS using DAVID bioinformatics resources. Pathways with Po0.001 are included in the table. Counts represent the number of matching
genes for each KEGG pathway.
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RNA puriﬁcation and quantitative real-time PCR
Total RNA was prepared using TRIzol (Invitrogen, Carlsbad, CA) for
cellular samples or the MagNA Pure Compact RNA Isolation Kit
(Roche Applied Science, Mannheim, Germany) for frozen tissue
samples (−80 °C). RNAs were checked for DNA contamination with
the appropriate primers. Reverse transcription was conducted using
reverse-transcribed murine Moloney leukemia virus reverse tran-
scriptase (Invitrogen) with oligo(dT) primers (Invitrogen) for mRNA
quantiﬁcation and random primers (Promega, Madison, WI) for pre-
mRNA quantiﬁcation.
Ribonucleoprotein immunoprecipitation analyzed by
high-throughput sequencing
To limit individual genetic variation, we pooled ﬁve LS and ﬁve NLS
samples for each HuR or mock IP. Frozen samples (−80 °C) were
disrupted using the MagNA Pure Instrument (Roche Applied
Science). IPs of endogenous RNA-protein complexes from LS and
NLS were evaluated as previously described (Peritz et al., 2006) using
Protein A-Sepharose (Sigma-Aldrich, St Louis, MO) that had been
pre-coated with 60 μg of anti-HuR or isotype control (mock)
antibodies. RNA-Seq is described in the Supplementary Materials
and Methods online.
Skin inﬂammation models
C57BL/6 mice (Charles River Laboratories, Chatillon-sur-Chalaronne,
France) were treated daily on shaved back skin with either 5% SDS
in phosphate-buffered saline, CompC-HCl (Merck, Darmstadt,
Germany) in 50% ethanol, or the control (50% ethanol). Two weeks
later, the mice were killed, and the skin was excised. Two
independent experiments consisting of at least three mice in each
group were performed. The Ethics Committee on Animal Research of
Languedoc-Roussillon, France, has approved this study (CEEA-
LR-12069).
Statistical analyses
The values are expressed as the means± SEM. The data were
analyzed using an unpaired two-tailed Student’s t-test, or a paired
Wilcoxon test, or Spearman’s rank correlation. Changes were
identiﬁed as signiﬁcant if the P-value waso0.05. P-values associated
with RIP-Seq functional annotations were derived using DAVID
bioinformatics resources (Huang et al., 2009).
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